Improving Patient Wellbeing With VNS Therapy

VNS Therapy addresses multiple dimensions of efficacy, providing a comprehensive treatment for a complex disease.

Benefits may include:

Fewer seizures

Shorter seizures

Faster recovery

Decreased seizure severity

Fewer medications

Improved alertness, mood, and memory

Improved quality of life

VNS Therapy side effects

VNS Therapy usually has mild side effects

Side effects are typically related to stimulation, are usually temporary, and may improve over time.

Common side effects include:

Hoarseness/change in voice
Coughing
Throat tickling
Feeling of shortness of breath

If side effects ever become uncomfortable, talk to your doctor. He or she may be able to lower stimulation levels to better meet your needs.

VNS Therapy is not a drug

Many VNS Therapy patients report positive outcomes without the kinds of side effects typically associated with epilepsy medications.

VIEW INDICATION AND IMPORTANT SAFETY INFORMATION

Easy-to-use treatment¹

Built-in compliance
No drug interactions
Short procedure, typically about an hour
Can be safely used in combination with any approved therapy at any time

VNS Therapy Is Customizable to Patient Needs

VNS Therapy offers advantages over older technologies, including greater control over devices and monitoring feedback to match the critical needs of each patient.

Magnet Mode

Manual delivery of an extra dose of therapy as needed; may be used during Standard Mode and Detect & Respond Mode.

Detect & Respond Mode

Responsive automatic delivery of an extra dose of therapy when a rapid increase in heart rate is detected that may be associated with seizures.

A complex disease requires a comprehensive approach

VNS Therapy delivers an anticonvulsive effect via multiple pathways

VNS Therapy works via several pathways:

References

1. Data on File, LivaNova, Houston, TX. 2. Koo B. J Clin Neurophysiol. 2001; 434-441. 3. Roosevelt et al. Brain Res. 2006; 124-132. 4. Ben-Menachem et al. Epilepsy Res. 1995;221-227. 5. Vonck et al. Seizure. 2008.05.001.